Law firms Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business · 1 February 2016 · 1 min read Corporate and M&A Cravath, Swaine & Moore Kirkland & Ellis Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryTrading Places: White & Case hires Mayer Brown funds head as former Freshfields US disputes head decamps for DLALaw firmsEliza Winter21 Aug 2026Sports is the new private capital frontier – why top firms are upping their gameLaw firmsMatthias Bergg14 Aug 2026Orrick hires Kirkland partner as global capital markets headLaw firmsKate Peacock13 Aug 2026Latham’s Freshfields hires continue with senior Hong Kong corporate duoLaw firmsWill Lewallen28 Aug 2026Simpson Thacher hits Weil for London corporate partnerLaw firmsTom Cox26 Aug 2026Latham and Skadden lead on Shein’s Hong Kong IPO as retailer targets $1.8bnLaw firmsEliza Winter24 Aug 2026Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025Five partners vie to succeed Hoyland as Simmons managing partnerLaw firmsTom Cox7 Jan 2025‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryLaw firmsAnna Huntley7 Jan 2025